TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,517
|
4,583
|
4,570 |
Financial expenses |
167
|
117
|
148 |
Earnings before taxes |
-49
|
-60
|
-17 |
EBITDA |
617
|
557
|
631 |
Total assets |
2,351
|
2,755
|
3,266 |
Current assets |
895
|
801
|
821 |
Current liabilities |
399
|
755
|
1,296 |
Equity capital |
343
|
391
|
451 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
14.6%
|
14.2%
|
13.8% |
Turnover per employee |
4,517
|
2,292
|
2,285 |
Profit as a percentage of turnover |
-1.1%
|
-1.3%
|
-0.4% |
Return on assets (ROA) |
5.0%
|
2.1%
|
4.0% |
Current ratio |
224.3%
|
106.1%
|
63.3% |
Return on equity (ROE) |
-14.3%
|
-15.3%
|
-3.8% |
Change turnover |
-66
|
13
|
610 |
Change turnover % |
-1%
|
0%
|
15% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.